Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors
- 1 June 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 290 (1) , 29-36
- https://doi.org/10.1016/0922-4106(95)90013-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptorsEuropean Journal of Pharmacology, 1994
- Dopamine D3 Receptor: Basic and Clinical AspectsClinical Neuropharmacology, 1993
- Molecular Diversity of the Dopamine ReceptorsAnnual Review of Pharmacology and Toxicology, 1993
- Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonistEuropean Journal of Pharmacology, 1992
- Biosensors based on the energy metabolism of living cells: The physical chemistry and cell biology of extracellular acidificationBiosensors and Bioelectronics, 1992
- Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapineNature, 1991
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleusNature, 1990
- Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analog of apomorphineJournal of Medicinal Chemistry, 1987
- Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptorsMolecular and Cellular Endocrinology, 1984